Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge

Annals of Allergy, Asthma and Immunology

Volumn 94, Issue 6, 2005, Pages 675-681

  Lipworth, Brian J ^a   Sims, Erika J ^a   Das, Sudip K ^b   Buck, Helen ^b   Paterson, Michelle ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Innovata Biomed Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; BECLOMETASONE; BUDESONIDE; CROMOGLYCATE DISODIUM; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; NITRIC OXIDE; SALBUTAMOL; SALMETEROL; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EOSINOPHIL; EXPIRATORY RESERVE VOLUME; FEMALE; HUMAN; MALE; POWDER INHALER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPIROMETRY; TREATMENT OUTCOME;

EID: 20544455549     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61327-0     Document Type: Article

References (31)

1. van der Palen J. Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check DIAL). Respir Med. 2003;97:285-289.
2. Newhouse MT, Nantel NP, Chambers CB, Pratt B, Parry-Billings M. Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow rates. Chest. 1999;115:952-956.
3. Barnes PJ, Pedersen S, Busse W. Efficacy and safety of inhaled corticosteroids: new developments. Am J Respir Crit Care Med. 1998;157:S1-S53.
4. Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol. 1999;104:1215-1222.
5. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410-418.
6. Lee DK, Gray RD, Lipworth BJ. Adenosine monophosphate bronchial provocation and the actions of asthma therapy. Clin Exp Allergy. 2003;33:287-294.
7. Doull IJM, Sandall D, Smith S, Schreiber J, Freezer NJ, Holgate ST. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′ monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatr Pulmonol. 1997;23:404-411.
8. Wilson AM, Lipworth BJ. Dose response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med. 2000;108:269-275.
9. O'Connor BJ, Ridge SM, Barnes PJ, Fuller RW. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis. 1992;146:560-564.
10. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor BJ. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma. J Allergy Clin Immunol. 2002;110:603-606.
11. Phillips K, Oborne J, Lewis S, Harrison TW, Tattersfield AE. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax. 2004;59:26-30.
12. Tan KS, McFarlane LC, Lipworth BJ. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill. Am J Respir Crit Care Med. 1997;155: 1273-1277.
13. American Thoracic Society. Standardization of spirometry: update. Am Rev Respir Dis. 1987;136:1285-1298.
14. Kharitonov SA, Chung KF, Evans D, O'Connor BJ, Barnes PJ. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med. 1996;153:1773-1780.
15. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 1997;10: 1683-1693.
16. Finney DJ. Statistical Method in Biological Science. London, England: Griffin; 1978.
17. Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol. 1998;101:457-463.
18. Masoli M, Weatherall M, Holt S, Beasley R. Clinical dose-response relationship of fluticasone propionate in adults with asthma. Thorax. 2004;59:16-20.
19. Prosperini G, Rajakulasingam K, Cacciola RR, et al. Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation. J Allergy din Immunol. 2002;110:855-861.
20. Booms P, Cheung D, Timmers MC, Zwinderman AH, Sterk PJ. Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma. J Allergy Clin Immunol. 1997;99:330-337.
21. Phillips K, Oborne J, Harrison TW, Tattersfield AE. Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthma. Thorax. 2004;59:21-25.
22. Aziz I, Wilson AM, Lipworth BJ. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest. 2000;118: 1049-1058.
23. 20 methacholine. Am J Respir Crit Care Med. 2001;163:1546-1550.
24. Van Den Berge M, Kerstjens HAM, Postma DS. Provocation with adenosine 5′-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease. Clin Exp Allergy. 2002;32:824-830.
25. Van Den Berge M, Kerstjens HAM, de Reus DM, Koeter GH, Kauffman HF, Postma DS. Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia. Clin Exp Allergy. 2004;34:71-76.
26. 20 of methacholine. Am J Respir Crit Care Med. 2001;164:1127-1132.
27. 20 extrapolation. Chest. 1998;114:1796-1797.
28. Eckert B, Mitchell C. Histamine PC(20) extrapolation. Chest. 2000;117:294-295.
29. 20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J. 1993;6:670-679.
30. Olsson B. Aerosol particle generation from dry-powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med. 1995;8:S13-S19.
31. Sovijärvi AR, Haahtela T, Ekroos HJ, et al. Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment. Thorax. 2003;58:500-504.